Armata Pharmaceuticals Inc. buy me8
Start price
24.07.23
/
0%
€1.37
Target price
24.07.24
€1.00
Performance (%)
66.42%
End price
26.07.23
€2.28
Summary
This prediction ended on 26.07.23 with a price of €2.28. With a performance of 66.42% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Armata Pharmaceuticals Inc. | -5.042% | -5.042% |
| iShares Core DAX® | 2.831% | 1.236% |
| iShares Nasdaq 100 | 2.918% | 0.640% |
| iShares Nikkei 225® | 2.007% | -2.135% |
| iShares S&P 500 | 2.257% | 0.451% |
According to me8 what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Little innovation
Few uniques
Comments by me8 for this prediction
In the thread Armata Pharmaceuticals Inc. diskutieren
Buy Armata Pharmaceuticals Inc.
Kursziel gesetzt auf 1,0